Medicare Enrolled
Dr. Carlos Charles, M.D.
Dermatology · Fishkill, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Charles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Charles?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Charles
Dr. Carlos Charles is a dermatology specialist in Fishkill, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Charles performed 3,839 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Charles received a total of $8,441 from 37 pharmaceutical and/or device companies across 448 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Charles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 21% volume in NY
$8,441 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,839
Medicare services
Top 21% in NY for dermatology
Not available
Unique patients (not deduplicated)
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
770 | $67 | $197 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
674 | $6 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
416 | $93 | $278 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
377 | $77 | $227 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
370 | $44 | $149 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
325 | $89 | $254 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
279 | $78 | $246 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $46 | $124 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
101 | $112 | $363 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
85 | $45 | $112 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
70 | $55 | $158 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
70 | $1 | $2 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
35 | $41 | $127 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
27 | $93 | $259 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
23 | $112 | $282 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
14 | $66 | $216 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
13 | $107 | $279 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.7% high complexity
15.7% medium
83.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,441
Total received (2018-2024)
Avg $1,206/year across 7 years
Top 25% in NY for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
448
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,249
2023
$2,184
2022
$1,298
2021
$25
2020
$200
2019
$954
2018
$1,532
Payments by company (2024)
ABBVIE INC.
$618
E.R. Squibb & Sons, L.L.C.
$414
Lilly USA, LLC
$185
UCB, Inc.
$167
Regeneron Healthcare Solutions, Inc.
$145
Incyte Corporation
$124
Janssen Biotech, Inc.
$117
LEO Pharma Inc.
$99
Galderma Laboratories, L.P.
$96
Amgen Inc.
$74
Novartis Pharmaceuticals Corporation
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
PFIZER INC.
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Arcutis Biotherapeutics, Inc.
$17
Dermavant Sciences, Inc.
$13
Top 3 companies account for 54.1% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,048
ABBVIE INC.
$748
Regeneron Healthcare Solutions, Inc.
$746
Janssen Biotech, Inc.
$570
Lilly USA, LLC
$493
Novartis Pharmaceuticals Corporation
$487
AbbVie Inc.
$409
Sun Pharmaceutical Industries Inc.
$389
Galderma Laboratories, L.P.
$377
Celgene Corporation
$317
PFIZER INC.
$290
LEO Pharma Inc.
$286
Incyte Corporation
$284
Amgen Inc.
$274
UCB, Inc.
$270
AbbVie, Inc.
$234
GENZYME CORPORATION
$190
Arcutis Biotherapeutics, Inc.
$177
Mayne Pharma Inc.
$151
Taro Pharmaceuticals USA, Inc.
$126
TRIAD LIFE SCIENCES INC.
$88
Ortho Dermatologics, a division of Bausch Health US, LLC
$60
Fresenius Kabi USA, LLC
$46
SANOFI-AVENTIS U.S. LLC
$42
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Journey Medical Corporation
$38
Bayer HealthCare Pharmaceuticals Inc.
$36
Dermavant Sciences, Inc.
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
EPI Health, LLC
$28
Almirall LLC
$25
MAYNE PHARMA INC.
$21
Zimmer Biomet Holdings, Inc.
$20
Aclaris Therapeutics, Inc.
$20
Merz North America, Inc.
$18
DERMIRA, INC.
$16
Mylan Pharmaceuticals Inc.
$14
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cimzia · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Desonate · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · FINACEA · Finacea · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INNOVAMATRIX AC · LIBTAYO · OLUMIANT · ONEXTON · OPZELURA · Olux · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STERNALOCK BLU SYSTEM · Seysara · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · Winlevi · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
60
County median income
$97,273
Nearest hospital to ZIP centroid (approximate)
MONTEFIORE ST LUKE'S CORNWALL
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Charles is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Charles experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Charles performed 770 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Charles receive payments from pharmaceutical companies?
Yes. Dr. Charles received a total of $8,441 from 37 companies across 448 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Charles's costs compare to other dermatologists in Fishkill?
Dr. Charles's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Charles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Fishkill
Browse dermatologists in Fishkill ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NY
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NY
Which NY dermatologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology